Cargando…
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
An effective HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs). Broad and potent VRC01-class bNAbs have been isolated from multiple infected individuals, suggesting that they could be reproducibly elicited by vaccination. Several HIV-1 envelope-derived germline-targeti...
Autores principales: | Seydoux, Emilie, Wan, Yu-Hsin, Feng, Junli, Wall, Abigail, Aljedani, Safia, Homad, Leah J., MacCamy, Anna J., Weidle, Connor, Gray, Matthew D., Brumage, Lauren, Taylor, Justin J., Pancera, Marie, Stamatatos, Leonidas, McGuire, Andrew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127986/ https://www.ncbi.nlm.nih.gov/pubmed/33951425 http://dx.doi.org/10.1016/j.celrep.2021.109084 |
Ejemplares similares
-
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
por: Parks, K. Rachael, et al.
Publicado: (2019) -
Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
por: Gray, Matthew D., et al.
Publicado: (2022) -
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
por: Borst, Andrew J, et al.
Publicado: (2018) -
Adjuvants influence the maturation of VRC01-like antibodies during immunization
por: Knudsen, Maria L., et al.
Publicado: (2022) -
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)